Clinical Trial

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with rosacea.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-03-08; most recent amendment 2026-02-17.
Trial Details
NCT Number NCT06312813
Lead Sponsor Wright State University
Conditions Rosacea
Enrollment 48 participants
Start Date 2024-02-27
Primary Completion 2028-12-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-18